See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Chemical Class · Nuclear Receptors

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10008043 10-Nitrooleate 88127-53-1 >98% 2006-08-01 32.611804788214 10-nitrooleate 10-nitro-9-trans-Octadecenoic Acid oleic acids nitration 9-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes 32.611804788214
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 157.498670963781 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 157.498670963781
18570.1 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 >98% (isomer mixture) 88.400607734806 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPAR.gamma. PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 88.400607734806
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 26.555457335788 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 26.555457335788
10141 15-deoxy-Δ12,14-Prostaglandin J2-biotin - >98% 2005-10-11 34.721527229676 15-deoxy-12-14-prostaglandin-j2-biotin 15-deoxy-Δ12,14-PGJ2-biotin affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides 34.721527229676
10007235 15-deoxy-Δ12,14-Prostaglandin J2 Lipid Maps MS Standard 87893-55-8 ≥97% 2009-01-16 51.545994475138 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards 51.545994475138
10007912 20-carboxy Arachidonic Acid Exclusive 79551-84-1 >98% ✓ 2007-08-15 38.503038674033 20-carboxy-arachidonic-acid 20-COOH-AA 20-HETE metabolites PPAR.alpha. PPAR.gamma. vasorelaxation activators CYP4F3B hypertension cytochrome P450 CYP450 perioxisome proliferator activated receptor PPARs PPARalpha PPARgamma 38.503038674033
10008842 2,3-bis (4-Hydroxyphenyl) Propionitrile 1428-67-7 >98% 2007-07-26 63.880200276243 2-3-bis-4-hydroxyphenyl-propionitrile DPN estrogen receptors ER.beta. ER.alpha. SERM agonists transcription assays estrogens estradiol ERa ERb endocrinology 63.880200276243
90500 3-Thiatetradecanoic Acid 116296-31-2 >98% 2004-02-06 0.860817679558 3-thiatetradecanoic-acid 3-TDA thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis 0.860817679558
10008042 9-Nitrooleate 875685-44-2 >98% 2006-08-11 32.871104972376 9-nitrooleate 9-nitro-9-trans-Octadecenoic Acid oleic acids nitration 10-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes 32.871104972376
34405 9(R)-HETE Exclusive 107656-14-4 ≥98% ✓ 6.390331491713 9-r-hete hydroxy acids 9R-HETEs 9-HETEs fatty 9(r)-HETEs 9(R)HETEs 6.390331491713
10007417 9-Thiastearic Acid 106689-24-1 >98% 2005-07-20 0.963977900552 9-thiastearic-acid heteroatom-substituted fatty acids modulates extensions desaturating distribution phospholipids pools radiolabeled stearate oleate rat hepatocytes hepatoma cellshypolipidemic effects anti-obesity therapeutics 0.963977900552
10007686 Acetyl Podocarpic Acid Anhydride Exclusive 344327-48-6 >98% ✓ 2007-07-11 281.868121546961 acetyl-podocarpic-acid-anhydride APD receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis 281.868121546961
600130 ATF2 (Phospho-Thr69,71) Transcription Factor Assay Kit - 2009-11-11 21.891220492215 atf2-phospho-thr69-71-transcription-factor-assay-kit Activating Transcription Factor 2 kits measuring measurement assays tf activating DNA-binding proteins bZIP octameric cyclic AMP-responsive elements CRE promoter regions genes mediates mediation DNA damage controls phosphorylation/activation inflammatory cytokines UV irradiation alkylating compounds cells cellular stressors pThr69,71 Thr69 Thr71 JNK/p38 homodimers heterodimers ATF/CREB Fos Fra2 c-Jun CREB ATF1 cycles control drug resistance apoptosis tumorigenesis insulin biosynthesis non-radioactive detection detecting nuclear extracts ELISA enzyme-linked immunosorbent assay double-stranded dsDNA colorimetric 69 71 phosphorylated 21.891220492215
60924 Azelaoyl PAF - >98% 63.528618784530 azelaoyl-paf PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors 63.528618784530
70790 BADGE 1675-54-3 >85% 62.704119968429 badge Bisphenol A diglycidyl ether ligands ppar.gamma. ppargamma peroxisome proliferator-activated receptors antagonists nuclear receptors 62.704119968429
10009145 Bezafibrate 41859-67-0 >98% 2007-08-02 4.529834254143 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.529834254143
70750 Caffeic Acid phenylethyl ester 104594-70-9 >98% 26.063635359116 caffeic-acid-phenylethyl-ester 2-Phenylethyl Caffeate; CAPE; β-Phenylethyl Caffeate NF kB NF-kB NF-.kappa.B inhibits inhibitors inhibition antioxidants nuclear transcription factors propolis antimitogenic anticarcinogenic immodulatory anti-inflammatory inflammation bee nuclear receptors NF-kappaB nfkb nf-kb NF-.kappa.B 132031-37-9 caffeiate 26.063635359116
18590 CAY10410 596104-94-8 >98% (isomer mixture) 103.931657458564 cay10410 9,10-dihydro-15-deoxy-Δ12,14-Prostaglandin J2; 9,10-dihydro-15-deoxy-Δ12,14-PGJ2 PPAR.gamma. PPARgamma prostaglandins 9,10-dihydro-15-deoxy-delta12,14-PGJ2 9,10-dihydro-15-deoxy-d12,14-PGJ2 9,10-dihydro-15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands oxidative stress 103.931657458564
10006545 CAY10464 Exclusive 688348-37-0 ≥98% ✓ 2005-10-25 22.933107734806 cay10464 resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar intracellular transcription factors PAHs hydrocarbons antagonists receptors 22.933107734806
10006546 CAY10465 Exclusive 688348-33-6 >98% ✓ 2005-09-09 22.942331491712 cay10465 resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar 22.942331491712
10009017 CAY10514 868526-38-9 >98% 2007-01-24 3.998232044199 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 3.998232044199
10012682 CAY10585 934593-90-5 ≥97% 2008-11-06 51.046418047881 cay10585 Hypoxia Inducible Factor-1α Inhibitor HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition 51.046418047881
10009797 CAY10591 Exclusive 839699-72-8 >98% ✓ 2008-04-21 47.879042357274 cay10591 Sirtuin 1 Activator 3; SIRT1 Activator 3 p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic 47.879042357274
10012536 CAY10592 Exclusive 685139-10-0 ≥98% ✓ 2009-02-26 39.451790055248 cay10592 selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn 39.451790055248
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 47.998624923265 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 47.998624923265
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 4.740928176795 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 4.740928176795
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.833767955800 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.833767955800
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 2.659116022099 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology 2.659116022099
10009753 ChREBP DBD Western Ready Control - 2007-05-03 2.261740331491 chrebp-dbd-western-ready-control Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams Beuren Syndrome Chromosome Region 14 WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology 2.261740331491
71730 Ciglitazone 74772-77-3 ≥98% 56.195560020090 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 56.195560020090
10956 Clofibrate 637-07-0 ≥98% 2004-09-14 20.854229588704 clofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate 20.854229588704
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 22.251700429711 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 22.251700429711
10011269 Fulvestrant 129453-61-8 ≥98% 2009-02-24 20.630497237568 fulvestrant ICI 182,780; Faslodex® estrogen receptors ER ERα agonist antagonist activator breast cancers hippocampus neurons ICI182780 ZD182780 ZD9238 ZM182780 20.630497237568
10008613 GW 7647 265129-71-3 ≥98% 2006-08-02 16.717079715863 gw-7647 PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 16.717079715863
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 23.362681682957 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 23.362681682957
70785 GW 9662 22978-25-2 ≥98% 87.012878453038 gw-9662 GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis 87.012878453038
9000497 GW 9662-d5 Exclusive - ≥99% deuterated product ✓ 2009-09-30 44.903296500920 gw-9662-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs 44.903296500920
10010324 Harmine 442-51-3 ≥98% 2007-11-07 24.470236266450 harmine metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology 24.470236266450
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 131.388888888888
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 131.388888888888
75650 Hyperforin 11079-53-1 ≥90% 28.893011049723 hyperforin St. John's Wort Johns herbal herbs lipid signalling mediators cyp450-2D6 cytochromes cyp-2D6 steroid receptors SXR CYP-450-2D6 neuroscience endocrinology 28.893011049723
10004976 Leptomycin B 87081-35-4 >98% 2008-03-19 4.016298342541 leptomycin-b NSC 364372; Mantuamycin; LMB; Elactocin antibiotics cell cycles p53 antifungals proliferation nuclear transport inhibits inhibitors inhibition inhibiting export signals receptors NES RNA REV-response elements HIV-1 4D 3E3 4.016298342541
10006318 Levonorgestrel 797-63-7 >95% 2005-01-25 79.168237569061 levonorgestrel Norplant levonorgestrel progestins progesterones contraception steroids hormones replacement contraceptives uterine uterus pregnancy analogs ovulation inhibition inhibitors inhibits receptors PR endocrinology 79.168237569061
90290 MEDICA 16 87272-20-6 >98% 15.703287292818 medica-16 hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis 15.703287292818
10006317 Mifepristone 84371-65-3 >98% 2005-01-25 109.514550118389 mifepristone RU-486 progesterones estrogens estradiol cancers apoptosis RU486 uterine uterus pregnancy hormones receptors glucocorticoids steroids PR GR HRE response elements binding endocrinology 109.514550118389
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 45.398432320442 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 45.398432320442
10010184 NF-κB (p50) Western Ready Control - Whole cell lysate 2007-07-19 47.071057616416 nf-b-p50-western-ready-control Nuclear Factor-κB (p50); NF-κB1 western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals 47.071057616416
10006319 Norgestrel 6533-00-2 ≥95% 2005-01-25 74.124123556002 norgestrel Ovrette® levonorgestrel progestins progesterones contraception steroids hormones replacement estrogens contraceptives receptors PR uterine uterus pregnancy ovulation inhibition ihibits inhibitors endocrinology 74.124123556002
10009277 Nuclear Extraction Kit - 2007-05-11 89.398348680171 nuclear-extraction-kit assays kits proteins transcription factors cytoplasmic fractions cells tissue homogenates EMSA extracts electrophoretic mobility shift western blotting blots 89.398348680171
600060 p53 Total and p53 (Phospho-Ser392) Dual Staining Assay Kit - 2009-03-10 8.749264374872 p53-total-and-p53-phospho-ser392-dual-staining-assay-kit kits assays measuring measurements tumors treatments DyLightTM (-)-Nutlin-3 positive ontrols p53(Phospho-Ser392) dsDNA double-stranded suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous autosomal Li Fraumeni Syndromes nuclear extracts cell-based assays cell based assay cba 8.749264374872
71745 Pioglitazone 111025-46-8 >98% 43.330260457774 pioglitazone PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated rosiglitazone receptors activation selectively selectivity 43.330260457774
10028 Pioglitazone (potassium salt) - >98% 52.518184688240 pioglitazone-potassium-salt PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated receptors 52.518184688240
301710 PPARα Blocking Peptide - 5.008729281768 ppar-blocking-peptide Peroxisome Proliferator-activated Receptor α peroxisome proliferator-activated receptors peptides controls pparalpha ppar.alpha. antibodies nuclear reactors 5.008729281768
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 28.164267955801 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 28.164267955801
101710 PPARα Polyclonal Antibody - 24.229699201964 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor α peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis 24.229699201964
10006915 PPARα Transcription Factor Assay Kit - 2005-08-25 32.840877478063 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 32.840877478063
10008878 PPARα, δ, γ Complete Transcription Factor Assay Kit - 2006-08-22 50.811397000789 ppar-complete-transcription-factor-assay-kit PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric 50.811397000789
301700 PPARγ Blocking Peptide - 3.756546961326 ppar-blocking-peptide Peroxisome Proliferator-activated Receptor γ peroxisome proliferators activated receptors controls immunohistochemistry IHC Western blotting WB PPAR.gamma. PPARgamma blots peptides antibodies 3.756546961326
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 21.181080417433 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 21.181080417433
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 61.004459352801 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 61.004459352801
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.257910597690 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.257910597690
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 19.116820135051 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 19.116820135051
71000 PPARγ Ligand Pack - >98% 64.870607734806 ppar-ligand-pack Peroxisome Proliferator-activated Receptor γ Pack ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs 64.870607734806
101700 PPARγ Polyclonal Antibody - 13.619415943173 ppar-polyclonal-antibody Peroxisome Proliferator-activated Receptor γ peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors 13.619415943173
10006855 PPARγ Transcription Factor Assay Kit - 2005-08-25 58.305307550644 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 58.305307550644
10006247 PPARδ Blocking Peptide - >70% 2004-11-09 4.339226519337 ppar-blocking-peptide PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 4.339226519337
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.494211172498 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.494211172498
101720 PPARδ Polyclonal Antibody - 2004-11-05 18.859161225514 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 18.859161225514
10006914 PPARδ Transcription Factor Assay Kit - 2005-08-23 35.103345994475 ppar-transcription-factor-assay-kit Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF 35.103345994475
10009568 PPARδ Western Ready Control - 2007-02-02 5.079270718232 ppar-western-ready-control Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity 5.079270718232
10008841 Propylpyrazole Triol 263717-53-9 >98% 2007-01-25 78.562078729281 propylpyrazole-triol PPT 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology 78.562078729281
11017 Retinoic Acid New 302-79-4 ≥98% 2011-10-25 11.043295402707 retinoic-acid ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans 11.043295402707
11002 Retinoid-Related Orphan Receptor γ Monoclonal Antibody (Clone 4G419) - 2011-08-09 12.191988950276 retinoid-related-orphan-receptor-monoclonal-antibody-clone-4g419 RAR-Related Orphan Receptor; ROR-γ; NR1F3 antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells 12.191988950276
11003 Retinoid-Related Orphan Receptor γ Polyclonal Antibody - 2011-08-09 12.191988950276 retinoid-related-orphan-receptor-polyclonal-antibody RAR-Related Orphan Receptor γ; NR1F3; ROR-γ antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells RAR 12.191988950276
71740 Rosiglitazone 122320-73-4 >98% 142.434901341752 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 142.434901341752
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 39.880375690608 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 39.880375690608
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 99.240115519839 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 99.240115519839
10922 SR 1001 - ≥98% 2011-06-28 82.680272954083 sr-1001 inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 82.680272954083
10026 T0070907 313516-66-4 >98% 65.236381215470 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 65.236381215470
71810 T0901317 293754-55-9 >98% 287.964116022099 t0901317 agonists to901317 TO-901317 T-0901317 t0-901317 receptors lipid nuclear hormone LXR.alpha.nuclear receptors LXR.beta. LXRalpha LXRbeta atherosclerosis 287.964116022099
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 43.010149960536 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 43.010149960536
10006321 Tibolone 5630-53-5 >98% 2005-01-25 49.142074334505 tibolone Liviella; Livial steroids estrogens estradiols osteoporosis postmenopausal proestrogenic 3.alpha.-hydroxy 3a-hydroxy 3.beta.-hydroxy 3b-hydroxy androgenic climacteric bones symptoms menopause transition effects mass endocrinology 49.142074334505
89730 Trichostatin A 58880-19-6 >98% 156.614143646409 trichostatin-a TSA reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers 156.614143646409
71750 Troglitazone 97322-87-7 >98% 165.226773480663 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 165.226773480663
70730 Wy 14643 50892-23-4 >98% 112.485773480663 wy-14643 Pirinixic Acid activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 112.485773480663
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?